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Abstract: The goal of this study was to develop near-infrared (NIR) resonant gold-gold sulfide 
nanoparticles (GGS-NPs) as dual contrast and therapeutic agents for cancer management via 
multiphoton  microscopy  followed  by  higher  intensity  photoablation. We  demonstrate  that 
GGS-NPs exposed to a pulsed, NIR laser exhibit two-photon induced photoluminescence 
that can be utilized to visualize cancerous cells in vitro. When conjugated with anti-HER2 
antibodies, these nanoparticles specifically bind SK-BR-3 breast carcinoma cells that over-
express the HER2 receptor, enabling the cells to be imaged via multiphoton microscopy 
with an incident laser power of 1 mW. Higher excitation power (50 mW) could be employed 
to induce thermal damage to the cancerous cells, producing extensive membrane blebbing 
within seconds leading to cell death. GGS-NPs are ideal multifunctional agents for cancer 
management because they offer the ability to pinpoint precise treatment sites and perform 
subsequent thermal ablation in a single setting.
Keywords: cancer, nanomedicine, multiphoton microscopy, photoluminescence, photothermal 
therapy, theranostics
Introduction
Development of superior diagnostic and therapeutic tools for cancer is crucial, as the 
age-adjusted mortality has remained relatively unchanged for the past 35 years despite 
use of currently available technologies.1 Researchers have recently begun to engineer 
multifunctional nanoparticles with properties suitable for both imaging and treatment 
of cancer in an effort to better manage the disease.2 Here we present GGS-NPs as a dual 
contrast and therapeutic agent when combined with two-photon microscopy. These 
nanoparticles strongly absorb NIR wavelengths of light which penetrate deeply into 
tissue,3 rendering them useful for NIR photothermal cancer therapy and optical imaging. 
Several gold-based NIR-absorbing nanoparticles, including silica-gold nanoshells,4–8 
gold nanorods,9–12 and gold nanocages,13 have demonstrated the ability to convert 
incident light energy into heat sufficient to irreversibly damage targeted cancerous cells. 
A promising alternative to conventional treatment modalities, nanoparticle-assisted 
photothermal therapy is minimally invasive, highly effective, and anticipated to have 
limited side effects. Additionally, the ability to image nanoparticles prior to treatment 
will prevent inadvertent delivery of heat to healthy tissue by helping distinguish normal 
from diseased regions. Although optical coherence tomography4 and photoacoustic 
tomography14–16 have been evaluated with gold-based NIR-absorbing nanoparticles as 
contrast agents, these techniques are limited to wide field-of-view applications. A more International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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promising imaging modality is multiphoton microscopy, 
which offers the advantage of providing high resolution at the 
microscopic level with the ability to obtain both functional 
and morphological information.
Nonlinear optics has historically been used to evaluate 
fluorescent signals in cell and animal model studies.17 
Multiphoton microscopy incorporates an ultrafast pulsed 
laser to deliver two NIR photons simultaneously to 
fluorophores, thereby producing images with superior 
resolution since NIR light interferes minimally with 
tissue and only molecules at the focal plane of the laser 
become excited. Although fluorophores are the traditional 
contrast agents for two-photon microscopy, recent work 
has demonstrated that nanoparticles with strong surface 
plasmon resonance in the NIR can be employed as well. 
Advances in this research area were made following the 
discovery that roughened metal surfaces exhibit two-
photon induced photoluminescence (TPL), a phenomenon 
attributed to coupling of light with localized plasmon 
resonances.18 Similarly, NIR-resonant nanoparticles 
excited with a pulsed laser luminesce when electrons in 
the sp-band recombine with holes in the d-band created 
following sequential absorption of single photons.19 TPL 
of gold nanoshells and nanorods has been extensively 
studied and these nanoparticles display enhanced proper-
ties for multiphoton microscopy compared to traditional 
fluorophores, including brighter signals and increased 
resistance to photobleaching.10,12,20–25 Specifically, it has 
been demonstrated that the TPL signal of a single nanorod 
is nearly 60 times brighter than a single rhodamine 6G 
molecule,22 and nanoshells are approximately 140 times 
brighter than fluorescent beads and display brightness on 
the same order of magnitude as nanorods.21 The enhanced 
luminescent signal reported for gold-based nanoparticles 
compared to traditional fluorophores and the ease of 
conjugation of biomolecules to gold surfaces renders 
these materials ideal contrast agents for multiphoton 
microscopy.
In this work we combined imaging and therapy of targeted 
cancer cells in one system through implementation of 
two-photon microscopy in conjunction with functionalized, 
NIR-absorbing GGS-NPs. These nanoparticles were first 
developed by Zhou et al and described to have a core/shell 
structure.26 Zhang and colleagues then proposed a gold 
nanoparticle aggregate structure.27 Due to consequent debate 
about their composition,28–30 specific structural details must 
be further elucidated. Despite this, potential applications 
of these nanoparticles reported in the literature continue to 
grow. GGS-NPs have been used as drug carriers with minimal 
toxicity31,32 and have more recently been described as a pho-
tothermal cancer therapeutic agent.33 Gobin et al found that 
GGS-NPs are as effective as silica-gold nanoshells at elimi-
nating tumors in vivo by photothermal ablation while also 
possessing a better distribution profile, with a higher ratio of 
nanoparticle accumulation in tumors versus organs associated 
with the reticuloendothelial system.33 This finding can likely 
be attributed to the smaller size of GGS-NPs (25–50 nm 
diameter) compared to silica-gold nanoshells (120–150 nm 
diameter). Together, the small size and apparent non-toxicity 
of GGS-NPs make them suitable as dual contrast and thera-
peutic agents for in vivo cancer management applications.
Here we demonstrate a proof-of-concept that GGS-NPs 
can be used simultaneously as targeted contrast agents and 
mediators of photothermal therapy by exploiting their optical 
properties and gold surface chemistry. GGS-NPs were 
specifically targeted towards SK-BR-3 breast carcinoma 
cells, which over-express the HER2 receptor,34 by function-
alizing the gold surface with anti-HER2 antibodies. This is, 
to our knowledge, the first report that describes antibody 
conjugation to GGS-NPs and subsequent nanoparticle 
binding to targeted cancerous cells. Upon exposure to a 
pulsed, NIR laser these GGS-NPs demonstrated TPL and 
could therefore be used to visualize SK-BR-3 cells in vitro 
via multiphoton microscopy with an incident power of 1 mW. 
In addition, increasing the power output of the excitation 
laser to 50 mW induced thermal damage to targeted cells and 
no damage to non-targeted cells. The ability to image these 
nanoparticles during their concurrent use as photothermal 
agents renders them highly attractive for use in cancer 
management, particularly in applications that require very 
specific therapy in order to maintain integrity of nearby vital 
regions of healthy tissue.
Material and methods
ggs-NP synthesis and functionalization
GGS-NPs were synthesized using a variation of the procedures 
described by Averitt et al35 and Schwartzberg et al.30 Solutions 
of HAuCl4 (2 mM, Alfa Aesar, Ward Hill, MA) and Na2S2O3 
(1 mM, Sigma, Saint Louis, MO) were prepared in milli-Q 
water, aged two days at room temperature, and mixed in 
small quantities at volumetric ratios ranging from 1:1 to 1:2 
(HAuCl4:Na2S2O3). The ratio that produced nanoparticles 
resonant near 800 nm as determined with a UV-visible 
spectrophotometer (Cary 50, Varian, Walnut Creek, CA) 
was used to synthesize a large batch of nanoparticles for 
in vitro experiments.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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GGS-NPs were visualized with transmission electron 
microscopy and the diameter of at least 50 nanoparticles 
per sample was measured with ImageJ software (NIH, 
Bethesda, MD). Calculation of the mean diameter revealed 
a slight batch-to-batch variability in average particle size, 
which ranged from 26 nm to 37 nm. In the initial reaction 
solutions we also observed ∼5 nm diameter colloidal gold 
and 50–100 nm flat triangular nanoparticles; however, 
most of these particles were removed from solution by 
a multi-step centrifugation process so the final product 
used in experiments consisted of a majority of GGS-NPs. 
Dynamic light scattering was also incorporated to assess 
nanoparticle size and analysis of multiple batches with a 
ZetaSizer NanoZS (Malvern Instruments, Worcestershire, 
UK) revealed an average hydrodynamic diameter of 42.2 nm, 
in good agreement with the transmission electron microscopy 
(TEM) results.
GGS-NPs were conjugated to either anti-HER2 (Neo-
Markers, Freemont, CA) or nonspecific anti-IgG (Sigma) anti-
bodies using 2,000 Da orthopyridyl-disulfide-poly(ethylene 
glycol)-N-hydroxysuccinimide (OPSS-PEG-NHS, Creative 
PEGWorks, Winston Salem, NC) as a linker. PEG-antibody 
conjugates were prepared by reacting one part 125 µM OPSS-
PEG-NHS with 9 parts 1 mg/mL antibody at 4°C overnight. 
This reaction produces a stable amide bond between primary 
amines on the antibody and carboxyl groups on the PEG 
chain that are exposed when the NHS terminus is cleaved 
in water. The particles were suspended in milli-Q water and 
exposed to PEG-antibody conjugates for 1 hour at 4°C at a 
100:1 volumetric ratio. Following antibody coupling, GGS-
NPs were reacted with a solution of mPEG-SH (5 mM, 5,000 
Da, Laysan Bio, Inc., Arab, AL) for a minimum of 4 hours 
at 4°C (1:200 volumetric ratio) to passivate any exposed 
gold surface area. GGS-NPs coated with mPEG-SH only 
(no antibody) were also synthesized for use as a negative 
control. Self-assembly of PEG-antibody and mPEG-SH onto 
the nanoparticle surface is possible due to dative interactions 
between sulfur and gold. Following antibody and/or PEG 
modification, GGS-NPs were centrifuged to remove unbound 
molecules, aspirated, and suspended in phosphate buffered 
saline (PBS) at an optical density of 2.0 (∼4.2 × 1011 particles/
ml) unless otherwise noted.
Quantification of antibody bound  
to nanoparticles
To verify that antibody and mPEG-SH successfully 
bound the GGS-NP surface we monitored changes in 
hydrodynamic diameter, which should increase upon addition 
of biomolecules. Using a Malvern ZetaSizer NanoZS, four 
nanoparticle formulations were studied: (1) Bare GGS-NPs, 
(2) GGS-NPs coated with mPEG-SH, (3) GGS-NPs coated 
with mPEG-SH and anti-IgG antibodies, and (4) GGS-NPs 
coated with mPEG-SH and anti-HER2 antibodies. The 
mean hydrodynamic diameter of each formulation was 
calculated as an average from three sets of nanoparticles, 
with individual sets also being tested in triplicate. Bare 
nanoparticles demonstrated a mean hydrodynamic diameter 
of 42.2 nm, which increased to 58.0 nm upon addition of 
mPEG-SH. A further increase occurred when either antibody 
formulation was included, with diameter of 69.8 nm for 
anti-IgG coated nanoparticles and 63.4 nm for anti-HER2 
coated nanoparticles. These results suggested the antibody 
and mPEG-SH were able to self-assemble on the nanoparticle 
surface using the disulfide or thiol terminus, respectively.
To quantify the amount of antibody present on the 
nanoparticles, targeted (coated with mPEG-SH and antibody) 
and control (only mPEG-SH coated) nanoparticles were 
incubated with 10 µg/ml horseradish peroxidase (HRP)-
conjugated goat anti-mouse IgG (for quantification of mouse 
anti-human HER2) or HRP-conjugated rabbit anti-goat 
IgG (for quantification of goat anti-mouse IgG) (both HRP 
antibodies from Sigma). Nonspecific reaction sites were 
blocked with a 3% solution of bovine serum albumin (BSA, 
Sigma) in PBS. To remove unbound HRP-labeled antibodies, 
the nanoparticles were centrifuged twice at 1500 g for eight 
minutes and suspended in 3% BSA. The HRP bound to 
GGS-NPs was developed with 3,3’,5,5’-tetramethylbenzidine 
dihydrochloride (Sigma) for 15 minutes and the reaction 
was stopped by addition of 2M sulfuric acid. The developed 
HRP was compared to a standard curve of the appropriate 
HRP-conjugated anti-IgG by determining the absorbance 
at 450 nm with a spectrophotometer. The total amount of 
peroxidase-labeled anti-IgG present in solution was divided 
by the total number of GGS-NPs in solution to determine 
the number of antibodies per nanoparticle. The number of 
nanoparticles was calculated from the Beer-Lambert law 
with the extinction coefficient of GGS-NPs derived from 
Mie theory as described by Averitt et al.35
cell culture
SK-BR-3 breast carcinoma cells (American Type Culture 
Collection, Manassas, VA), which over-express the HER2 
receptor,34 were cultured in McCoy’s 5A growth medium 
(Sigma) containing 10% fetal bovine serum and 1% 
penicillin-streptomycin at 37°C in a 5% CO2 environment. 
For experiments, cells transferred to 15 mL conical tubes International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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(6 × 105 cells/tube) were centrifuged (115 g, 3 minutes) to 
form pellets that were subsequently suspended in 1 mL of 
one of the four following solutions: (1) nanoparticles coated 
with anti-HER2 and mPEG-SH, (2) nanoparticles coated 
with anti-IgG and mPEG-SH, (3) nanoparticles coated with 
only mPEG-SH, or (4) PBS. The nanoparticle solutions 
consisted of approximately 4.2 × 1011 GGS-NPs. Cells were 
incubated in these suspensions for 30 minutes at 37°C in a 
hybridization chamber (VWR International, West Chester, 
PA) with constant rotation at 7 rpm. Following incubation, 
the samples were centrifuged (115 g, 3 minutes), aspirated, 
and diluted in PBS to remove any particles not bound to the 
cells. This rinsing procedure was repeated thrice followed by 
resuspension in growth media (1 mL). The cells were cultured 
on chambered coverglass overnight before experiments were 
performed. For studies of the effect of thermal therapy on 
cell membrane structure, the cells were labeled with 5 µM 
DiI (Molecular Probes, Eugene, OR) for 10 minutes prior to 
incubation with the nanoparticles as described above.
Multiphoton microscopy  
and photothermal therapy
A Zeiss Laser Scanning Microscope (LSM) 510 META (Carl 
Zeiss, Inc., Thornwood, NJ) equipped with a femtosecond-
pulsed Ti:sapphire laser source (Chameleon, Coherent, Inc., 
Santa Clara, CA) was used to perform multiphoton microscopy 
and photothermal therapy experiments. The wavelength of the 
output laser beam was tuned to match the peak extinction of 
the GGS-NPs and operated with a pulse width of 140 fs and 
repetition rate of 90 MHz. A short-pass dichroic mirror was 
used to reflect incident NIR light onto the sample through 
a 20× objective (numerical aperture (NA) = 0.75) or a 63× 
objective (NA = 1.4) and to collect photoluminescence. 
Background signal was reduced with an infrared-blocking 
filter and the META detector was used to collect TPL from 
the GGS-NPs between 451–644 nm.
For imaging nanoparticles on cells, incident laser power 
was 1 mW with a pixel dwell time of 12.8 µsec and the laser 
beam was raster-scanned across a 450 µm × 450 µm area. 
Calculating laser intensity by dividing power by the area of 
the Airy disc, this corresponds to a fluence of 0.96 J/cm2. To 
perform photothermal ablation, the samples were reposi-
tioned and laser power was increased to 50 mW (48.1 J/cm2) 
while maintaining the same dwell time. Samples were treated 
with a single pass of the laser. One hour after laser treatment 
cell viability was assessed by labeling cells with Calcein AM 
(1 µM, Molecular Probes, Eugene, OR), a live cell stain, and 
ethidium homodimer-1 (4 µM, EthD-1, Molecular Probes), a 
dead cell stain. Fluorescence microscopy was performed with 
an inverted Zeiss Axiovert 135 phase contrast microscope 
(Carl Zeiss).
Results
ggs-NP characterization
Visualization of GGS-NPs with transmission electron 
microscopy (Figure 1a) and subsequent analysis with 
ImageJ software revealed slight batch-to-batch variability 
in nanoparticle size, with the smallest batch of nanoparticles 
produced having a diameter of 26 ± 2 nm and the largest 
having diameter of 37 ± 4 nm. Variations in nanoparticle 
diameter did not affect microscopy or photoablation results 
when experiments were repeated using separate nanoparticle 
batches. Dynamic light scattering revealed an average hydro-
dynamic diameter of 42.2 nm, in good agreement with the 
TEM results. GGS-NPs are thus less than one-third the size 
of silica-gold nanoshells,36 and similar in size to nanorods37,38 
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Figure 1 a) TeM of ggs-NPs. scale bar = 40 nm. b) extinction spectrum of the ggs-NPs. c) ggs-NPs displayed a quadratic dependence of luminescence intensity on 
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and nanocages.39 Although ∼5 nm diameter colloidal gold 
and 50–100 nm flat triangular nanoparticles were present 
in the initial nanoparticle solution, most of these particles 
were removed by centrifugation so the final product used in 
experiments consisted of a majority of GGS-NPs. Extinction 
characteristics were determined with a spectrophotometer 
and GGS-NPs had a peak plasmon resonance centered around 
800 nm with a second extinction peak present at 530 nm due 
to remaining colloidal gold (Figure 1b). These findings are 
consistent with the synthesis and purification of GGS-NPs 
described by Gobin et al.33
Antibody coverage was quantified with a modified 
enzyme-linked immunosorbent assay (ELISA) and both 
anti-HER2 and anti-IgG coated GGS-NPs bound signifi-
cantly more HRP-antibodies than PEG-coated GGS-NPs 
(P < 0.01 for both). The ELISA on anti-HER2 GGS-NPs 
indicated 55.0 ± 4.0 antibodies per nanoparticle while control 
GGS-NPs remained free of antibody (−1.3 ± 2.6 antibodies/
nanoparticle). Similar antibody densities were obtained for 
anti-IgG GGS-NPs compared to control GGS-NPs, with 
targeted nanoparticles bearing 32.6 ± 3.2 antibodies per 
nanoparticle and control GGS-NPs showing negligible back-
ground (−1.1 ± 1.5 antibodies/nanoparticle).
ggs-NPs exhibit two-photon  
induced photoluminescence
The ability of GGS-NPs to produce TPL was probed by 
imaging particles in aqueous solution with the multiphoton 
microscope with excitation power ranged from 1–10 mW. 
The average emission intensity was determined using 
ImageJ software (NIH) and plotted versus excitation power. 
A quadratic dependence of nanoparticle emission intensity 
as a function of incident laser power was observed, with the 
slope of the fit linear curve being 2.06 ± 0.03, indicating a 
two-photon absorption process (Figure 1c).20−23 To compare 
brightness of the GGS-NP signal with reported values 
for other nanoparticle formulations we also synthesized 
and imaged spherical nanoshells consisting of a 120 nm 
diameter silica core and a 14.5 nm thick gold shell (mean 
particle diameter = 149 nm) using the procedure introduced 
by Oldenburg et al.36 Silica-gold nanoshells and GGS-NPs 
were prepared in aqueous solution to optical density 
(OD) 10 at 800 nm and 500 µL of each nanoparticle solu-
tion was placed in chambered coverglass. The samples were 
imaged with 1 mW and 10 mW excitation power at 800 nm 
and the mean intensity per particle was determined using 
ImageJ software (NIH). Analysis of several hundred particles 
of each type revealed that at 1 mW excitation, the brightness 
ratio of GGS-NPs to nanoshells was 1:1.03, indicating that 
GGS-NPs are on the same order of magnitude brightness as 
silica-gold nanoshells, which have already demonstrated suc-
cess as in vivo multiphoton contrast agents.21 When excitation 
power was increased to 10 mW, the brightness ratio of GGS-
NPs to nanoshells increased to 2.57:1. The damage threshold 
for silica-gold nanoshells has been reported as 4.5 mW and 
therefore, it is likely that the reduction in silica-gold nano-
shell luminescence was a result of particle melting.21 The 
GGS-NPs appear to have a higher damage threshold than 
silica-gold nanoshells, indicating they may convert more 
incident multiphoton energy to luminescence than to heat 
making them more suitable for combined diagnostic and 
therapeutic agents.
Antibody-functionalized ggs-NPs  
enable imaging and thermal ablation  
of targeted breast cancer cells
The application of GGS-NPs as dual agents for cancer 
imaging and treatment was investigated by utilizing low 
laser powers (1 mW) to image cancerous cells and high laser 
powers (50 mW) to induce cell death. To facilitate binding 
with SK-BR-3 breast carcinoma cells, GGS-NPs were 
functionalized with anti-HER2 antibodies (NeoMarkers) and 
backfilled with mPEG-SH (Laysan Bio, Inc.) as a blocking 
agent to prevent non-specific binding. Control GGS-NPs 
were coated with mPEG-SH either with or without anti-IgG 
antibodies. Results of two-photon microscopy performed 
with 1 mW incident power are displayed in Figure 2, 
where Figure 2a displays the TPL signal (observed only 
for anti-HER2 functionalized nanoparticles attached to 
SK-BR-3 cells), Figure 2b is a brightfield (BF) image of the 
same field of view, and Figure 2c is an overlay of the TPL 
and BF images. Successful targeting of SK-BR-3 cells with 
anti-HER2 functionalized GGS-NPs was demonstrated by 
the increased TPL signal intensity versus the controls as 
shown in Figure 2a. At this laser power, SK-BR-3 cells alone 
(samples incubated with PBS) did not exhibit a luminescent 
signal, thus any luminescence observed can be attributed to 
the presence of GGS-NPs. Cells that were incubated with 
nanoparticles coated with nonspecific antibodies or with 
only mPEG-SH could not be discerned thereby verifying the 
specific targeting of anti-HER2 functionalized nanoparticles 
to SK-BR-3 cells.
For nanoparticle assisted-laser therapy the samples were 
repositioned and laser power was adjusted from 1 mW 
to 50 mW. Figure 3 displays the results of the viability/
cytotoxicity assay performed after exposing cells to the International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Anti-HER2 Anti-lgG PEG PBS
(a)
(b)
(c)
Figure 2 a) Two-photon induced photoluminescence images of sK-Br-3 cells exposed to 1 mW with the pulsed laser tuned to 800 nm. b) Brightfield images of SK-BR-3 
cells in the same field-of-view as the luminescence images. c) Overlay of images (a) and (b), showing that luminescence was confined to cells targeted with anti-HER2 gold-
gold sulfide nanoparticles. Scale bar = 100 µm.
Anti-HER2 Anti-lgG PEG PBS
1 mW
50 mW
Figure 3 Calcein AM staining indicated that cancerous cells remained viable (evidenced by green fluorescent signal) when exposed to 1 mW laser power, regardless of 
nanoparticle presence. At 50 mW laser output a red fluorescent ethidium homodimer-1 signal indicative of membrane damage was observed in cells exposed to anti-HER2 
functionalized GGS-NPs only where the laser was applied. Laser exposure alone was harmless to cells, as was laser exposure combined with nonspecifically targeted 
nanoparticles. scale bar = 250 µm.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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nanoparticles and laser. No loss in cell viability was observed 
in samples exposed to 1 mW laser power indicating that 1 mW 
(0.96 J/cm2) is not enough power to induce localized heat-
ing of the nanoparticles in this time frame and can be safely 
implemented to image nanoparticle-targeted cells. Using 50 
mW laser power (48.1 J/cm2) samples exposed to irradiation 
only or to irradiation and control nanoparticles remained 
viable, while cell death was induced by thermal damage when 
cells were exposed to irradiation and anti-HER2 coated GGS-
NPs, as indicated by red EthD-1 fluorescence in the square-
shaped region where the laser beam was raster-scanned across 
the sample (Figure 3). Cells outside the laser path remained 
viable, demonstrating that the anti-HER2 coated GGS-NPs 
alone were not toxic. This is in keeping with results of prior 
studies that have examined and established the compatibility 
of GGS-NPs.31,32
Thermal ablation compromises 
membrane integrity to induce  
cell death
The results of the Calcein AM/Ethidium homodimer-1 
live/dead stain following laser exposure suggested that 
one mechanism of cell death was loss of membrane 
integrity caused by localized heating of the nanoparticles. 
Ethidium homodimer-1 is excluded from cells with an intact 
membrane; thus, the fluorescent EthD-1 signal observed in 
targeted SK-BR-3 cells exposed to the 50 mW laser indi-
cated that membrane integrity was compromised during 
photothermal therapy. To observe changes in membrane 
structure, SK-BR-3 cells were labeled with 5 µM DiI 
(Molecular Probes) for 10 minutes at 37°C prior to incuba-
tion with the anti-HER2 nanoparticles and subsequent laser 
treatment as described before. Targeted, DiI-labeled cells 
were exposed to high laser power (50 mW) and imaged with 
high-resolution (63X, NA = 1.4) time-lapse photography to 
monitor changes in membrane morphology. For this laser 
power, pixel dwell time, and numerical aperture the fluence 
was calculated to be ∼30 J/cm2. A 543 nm laser was used 
for DiI excitation while GGS-NPs were simultaneously 
excited with the pulsed 810 nm Ti:Sapphire laser. Mem-
brane morphology appeared normal before the laser was 
applied (t = 0 seconds), initial signs of membrane blebbing 
appeared within 10 seconds, and extensive damage due to 
hyperthermia occurred within 30 seconds (Figure 4). Control 
cells exposed to only the 50 mW laser did not display signs 
of membrane injury. During this study it was noted that 
constant excitation with the 50 mW pulsed laser caused the 
TPL signal observed from the GGS-NPs to diminish over 
time, which is consistent with the results of Huff et al who 
reported decreased signals for nanorods after prolonged 
exposure to a continuous wave laser operating between 7.5 
and 60 mW.10 This loss in signal is likely due to restructuring/
melting of the nanoparticles, although further studies need 
to be performed to confirm this hypothesis.
Discussion
Multifunctional nanoparticles have potential to fulfill the 
need for novel methods to detect and treat neoplasia that 
thoroughly eliminate disease and improve survival while also 
minimizing side effects. The objective of this study was to 
demonstrate that GGS-NPs can be used simultaneously as con-
trast and therapeutic agents using conventional multiphoton 
microscopy. In the foreseeable future, this technology will 
be limited to applications where the tumor is easily acces-
T = 0 sec T = 10 secT  = 30 sec
Figure 4 Time-lapse photography of SK-BR-3 cells exposed to anti-HER2 functionalized GGS-NPs and 50 mW laser power. The fluorescent red DiI membrane stain indicates 
regions of membrane blebbing generated by localized hyperthermia, with examples depicted by white arrows. scale bar = 20 µm.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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sible due to the restricted penetration depth of pulsed laser 
light and therefore we have used breast carcinoma as a 
model system. Epidermal growth factor receptor 2 (HER2) 
is amplified in approximately 30% of breast cancer cases 
and is associated with a poor prognosis clinically,40 so it is 
an excellent target for novel anti-cancer agents. We showed 
that GGS-NPs can be specifically targeted towards SK-BR-3 
breast carcinoma cells in vitro by functionalizing the gold 
surface with anti-HER2 antibodies, and that these targeted 
cells can be visualized using the two-photon induced lumi-
nescence of GGS-NPs under excitation with a low intensity 
pulsed NIR laser. Using a higher intensity of the laser induced 
nanoparticle heating leading to photothermal ablation of 
targeted cancer cells caused by membrane blebbing. This 
study provided a proof-of-concept that GGS-NPs used in 
conjunction with multiphoton microscopy can provide the 
ability to “see-and-treat” tumors in a single setting.
GGS-NPs offer several advantages that render them 
attractive among the growing list of gold-based nanoparticle 
regimens for cancer management. As previously men-
tioned, GGS-NPs are smaller than silica-gold nanoshells 
and nanorods, two of the most thoroughly studied gold-based 
nanotherapeutics, which should correlate with improved 
stability and enhanced tumor delivery in vivo.33,41 They also do 
not require capping with surfactants during synthesis which 
is beneficial not only because it eliminates toxicity concerns 
such as those associated with the cetyltrimethylammonium 
bromide (CTAB) surfactant used to prepare nanorods,42 
but also because it leaves the gold surface available for 
conjugation to biomolecules. In this work we provided the 
first demonstration of tethering antibodies to GGS-NPs by 
utilizing the available gold. Another advantage of GGS-NPs 
is that they absorb light more efficiently than nanoshells 
which should yield enhanced imaging and therapy. Though 
GGS-NPs have been studied for many years, we have only 
recently described their application in photothermal cancer 
therapy.33 In that work, a continuous wave laser was used to 
excite the GGS-NPs while in this work a pulsed laser was 
employed. Use of a pulsed laser not only provides a new 
imaging capability by producing TPL from the nanoparticles; 
it also enables simultaneous therapy and this is the first paper 
to report combined imaging and photothermal therapy with 
these nanoparticles. It should be noted that use of a high 
intensity pulsed laser also allows therapy to be achieved more 
rapidly and with lower total energy dosages than required 
for continuous lasers, which should cause significantly less 
heating and damage to surrounding tissue in vivo.
The main advantage of two-photon microscopy in medical 
imaging is the ability to provide sub-cellular resolution at 
depths of up to several hundred microns in tissue.17 Advance-
ment of this technology to the clinical setting is currently 
hindered by the cost and size of commercially available 
multiphoton microscopes; however, the price of femtosecond 
pulsed lasers should decrease as they become more commonly 
used and research to miniaturize two-photon microscopes 
and reduce their complexity is ongoing. Recent successes 
in development of two-photon endoscopes were achieved 
by incorporating microelectromechanical systems (MEMS) 
scanning mirrors into the microscope design.43,44 Specifically, 
Piyawattanametha et al have fabricated a lightweight (2.9 g), 
MEMS-based two-photon microscope and demonstrated its 
ability to track individual red blood cells flowing in neocorti-
cal microvasculature of adult mice, establishing the future 
potential for two-photon imaging in vivo.45 With further 
development, multiphoton microscopy combined with dual 
imaging and therapy GGS-NPs could provide an effective 
method to pinpoint and treat specific sites following initial 
tumor detection with wide-field imaging modalities. In one 
potential application, TPL of targeted nanoparticles could be 
used to indicate tumor margin status and any suspicious cells 
located could be eliminated by employing higher intensity 
photoablation, removing the need for biopsies and additional 
surgery. This ability to “see-and-treat” would be particularly 
beneficial when preservation of normal tissue surrounding 
neoplastic regions is critical.
Conclusion
The data presented confirms that NIR-absorbing GGS-NPs 
have properties that render them suitable as a multifunctional 
agent for cancer management using multiphoton microscopy. 
Nanoparticles functionalized with anti-HER2 antibodies 
bound effectively to SK-BR-3 breast carcinoma cells, while 
those coated with anti-IgG or mPEG-SH did not attach to 
cancer cells. Luminescence emitted by GGS-NPs upon 
excitation with a pulsed laser resulted from a two-photon 
absorption process and was as bright as luminescence 
emitted from silica-gold nanoshells. At 1 mW laser power, 
SK-BR-3 cells labeled with anti-HER2 GGS-NPs were 
safely visualized and upon increasing laser power to 50 mW 
cell death was induced following membrane blebbing. 
Nanoparticle heating and subsequent cell death was confined 
to the area where the laser beam was raster-scanned across 
the sample. Irradiation alone at either power did not generate 
changes in cell morphology or cause loss of viability.International Journal of Nanomedicine 2010:5 submit your manuscript | www.dovepress.com
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Our results indicate that GGS-NPs are an appropriate 
choice of combined therapeutic and diagnostic (theranostic) 
agent for use with multiphoton microscopy. GGS-NPs 
decorated with antibodies can provide enhanced contrast 
of targeted cancer cells versus non-targeted healthy cells at 
low incident powers; if imaging results suggest a region is 
highly malignant, a higher power laser can then be applied 
to induce localized heating of particles and subsequent 
hyperthermic damage to the suspicious lesion. Having the 
ability to visualize and treat tumor cells with high precision 
will improve cancer management by minimizing damage to 
normal tissue surrounding neoplastic regions. In addition, 
removing the waiting period between time of detection and 
time of treatment will prevent increases in tumor burden that 
cause eradication of the disease to become more difficult.
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